DESIREE BARCLIFT: Open Payments
NPI 1538408935 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 62 payments from 10 companies in 2025. Trend: 2023 $549 · 2024 $944 · 2025 $1,249
Food & beverage: $1,040Education: $209
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $647 |
| ABBVIE INC. | 9 | $238 |
| UCB, Inc. | 12 | $154 |
| Lilly USA, LLC | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Organon LLC | 3 | $36 |
| Celltrion USA Inc. | 1 | $25 |
| Reprise Biomedical, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: TREMFYA, RINVOQ, Bimzelx, EBGLYSS, SKYRIZI, VTAMA, VEGZELMA, Rhapsido.
Industry payments across ID — which companies pay providers there.
